BIBF 1120 (Nintedanib), a Triple Angiokinase Inhibitor, Induces Hypoxia but Not EMT and Blocks Progression of Preclinical Models of Lung and Pancreatic Cancer

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-12-0995
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)


Related search